Long queues for Covid-19 tests as an Omicron variant threaten

With the Omicron variant spreading faster than any other variant of coronavirus before it, the Biden White House has pushed for testing to be more accessible. You’ve been making this push for months, but critics say it’s nowhere near enough.

Supply just can’t keep up with demand, but with Omicron being so much more contagious, testing is becoming more important than ever, said Mara Aspinall, professor of practice at Arizona State University’s College of Health Solutions.

“We are in a very, very precarious moment,” said Aspinall. “Testing is our only exit strategy from all of this.”

If people don’t test, the country is at risk of the disease spreading further.

“Testing is the core because without it there is no way to isolate people,” said Aspinall.

Most of the diseases in the US are still caused by the Delta variant.

In addition to the usual demand for tests, the current surge is coming from people with a few different needs, she said. Some have symptoms and with the flu and other viruses floating around they want to know if they have Covid-19. Others want to test before getting on a plane or spending time with family over Christmas. Both are important reasons to take a test, she said, but the test pool is simply not ready for it.

“A week ago I thought we might have enough tests, but if Omicron lands at 200,000 or 300,000 cases a day, we probably don’t have enough tests,” said Aspinall. “At every stage we thought it was close enough and now we know it is not enough.”

Last week, White House Covid-19 Response Coordinator Jeff Zients insisted “there are many free tests across the country”.

Since then, cases have increased dramatically in some states. There are now an average of 121,707 new Covid-19 cases in the United States every day, according to Johns Hopkins University. The number of new cases has remained stable over the past week, but at a level last seen in September at the end of the summer increase. And falls are increasing much faster in parts of the Northeast, Midwest, and South.

White House press secretary Jen Psaki scoffed last week when asked if tests should be free and widely available.

“Shall we just send one to every American?” She asked.

However, similar initiatives are already in place at local level in some cities.

On Thursday, New York City Mayor Bill deBlasio announced The city would begin distributing half a million rapid home-use Covid-19 tests for free through community organizations. There are also programs in Ohio that distribute rapid tests through public libraries. A program called Say Yes! Covid Test sends home tests in certain zip codes.

While some public health experts have stated that they would like the federal government to send tests out to everyone, as it does in some European countries, Aspinall doesn’t think it is possible. The program would be expensive and could require additional funding from Congress that may not be provided. Second, not everyone who gets one would use the tests, and the tests are too important to be wasted.

When CNN’s Kaitlan Collins asked during a press conference Monday why the US government had not done rapid tests for free like other countries, Zients doubled down on his claim that the country had adequate testing.

“There is enough testing capacity in this country,” said Zients, adding that “the tests are free in many locations across the country.”
Zients said, “Our goal is to offer free trials to anyone who wants to do one as efficiently and effectively as possible.”

With this in mind, the Biden administration has taken steps to make Covid-19 tests more accessible.

As Dr. Rochelle Walensky, director of the US Centers for Disease Control and Prevention, said in a December 3 interview, the US is “doing a lot to expand testing,” including offering Covid-19 tests at major international airports and free PCR testing at 10,000 locations across the country.
In early December, President Joe Biden also announced that insurance companies would have to pay for home testing to curb a potential winter surge. It did so months after his government announced a $ 1 billion investment in rapid tests, which included retailers like Walmart, Amazon, and Kroger, who sell rapid home test kits at cost for three months.
However, experts say that while these efforts are a good start, they are nowhere near enough. Aspinall also said the country needs to step up programs like Say Yes Covid Test, which put more testing into the hands of people who can’t afford or don’t have access, and target areas that have a high social vulnerability index.

Why US Tests Are Delayed

The reasons why tests cannot keep up with demand vary.

Some problems stem from the testing industry. “Companies don’t always have enough staff to manage many third shifts,” said Aspinall.

The bigger problem, however, could be in the regulatory environment itself. Companies like Roche and Siemens have publicly stated that they have submitted their rapid Covid-19 tests for approval by the U.S. Food and Drug Administration, Aspinall said, but the tests have not yet been approved. The same test is already used in Asia. It’s unclear what the jam with the FDA is.

Test to Remain is working to keep students safe in school, CDC director says

“We have to find a way, human or otherwise, to get enough resources to the FDA,” said Aspinall.

Alex Tabarrok, an economics professor at George Mason University and co-author of a website on FDA policy and reform, told CNN, “The FDA has been too slow to approve rapid antigen tests. As a result, the prices for these tests are much higher in the US than in the rest of the world. ”

Michael Mina, a testing expert and epidemiologist who works as chief science officer at biotech software company eMed, believes the FDA is completely wrong about Covid-19 rapid tests. The agency considers these tests a medical device, and medical devices require “long, slow clinical trials that last months and months and millions of dollars”. He said the FDA should instead see them as a public health tool. Mina said he doesn’t want the FDA to accept lower quality tests, but lower sensitivity would be fine.

“When I think of public health, I need a very quick test. It doesn’t have to be as sensitive as a PCR test,” Mina said.

He said he has spoken to manufacturers who run many millions of tests every day that do not disrupt the US market because the standard is too high and many other countries are buying them.

“The FDA doesn’t seem to really budge. It’s such a terrible problem,” said Mina.

What is clear is that the country must do everything it can to improve access to testing, Aspinall said.

“Testing and isolating is the way to slow it down and stop it,” said Aspinall. “We can’t make any more victims to the virus.”

Comments are closed.